Form 4 Tracker
Kymera Therapeutics, Inc.
KYMR

46 insider filings · Latest: Jun 26, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 24, 2026Jun 24 9:29 PMAtlas Venture Opportunity Fund I, LP
Proposed Sale
16,542$98.25$1.6M

View →

Jun 23, 2026Jun 23 10:14 PMAtlas Venture Opportunity Fund I, LP
Proposed Sale
173$99.45$17.2K

View →

Jun 23, 2026Jun 23 10:14 PMAtlas Venture Fund X, LP
Proposed Sale
1,235$99.45$122.8K

View →

Jun 22, 2026Jun 23 1:02 AMBruce BoothDirector
Sale
31,798$103.75$3.3M613,762(I)

View →

Jun 22, 2026Jun 23 1:01 AMBruce BoothDirector
Sale
246,330$98.52$24.3M617,663(I)

View →

Jun 18, 2026Jun 23 1:01 AMBruce BoothDirector
Sale
115,056$91.01$10.5M647,914(I)

View →

Jun 17, 2026Jun 23 1:01 AMBruce BoothDirector
Sale
116,812$90.34$10.6M662,042(I)

View →

Jun 22, 2026Jun 22 9:47 PMNoah GoodmanChief Business Officer
Sale
2,500$99.00$247.5K50,195.438(D)

View →

Jun 22, 2026Jun 22 9:28 PMAtlas Venture Opportunity Fund I, LP
Proposed Sale
34,152$90.43$3.1M

View →

Jun 22, 2026Jun 22 9:28 PMAtlas Venture Fund X, LP
Proposed Sale
243,976$90.43$22.1M

View →

Jun 22, 2026Jun 22 8:46 PMNOAH GOODMAN
Proposed Sale
2,500$90.43$226.1K

View →

Jun 18, 2026Jun 18 9:35 PMAtlas Venture Opportunity Fund I, LP
Proposed Sale
14,128$89.90$1.3M

View →

Jun 18, 2026Jun 18 9:35 PMAtlas Venture Fund X, LP
Proposed Sale
100,928$89.90$9.1M

View →

Jun 17, 2026Jun 17 9:26 PMAtlas Venture Opportunity Fund I, LP
Proposed Sale
12,902$87.44$1.1M

View →

Jun 17, 2026Jun 17 9:25 PMAtlas Venture Fund X, LP
Proposed Sale
92,169$87.44$8.1M

View →

Jun 17, 2026Jun 17 9:25 PMBruce Booth
Proposed Sale
11,741$87.44$1.0M

View →

Jun 17, 2026Jun 17 8:43 PMJEREMY CHADWICK
Proposed Sale
66,893$87.44$5.8M

View →

May 27, 2026May 27 9:50 PMJeremy G ChadwickChief Operating Officer
Sale
4,279$81.58$349.1K44,018(D)

View →

May 26, 2026May 27 9:50 PMJeremy G ChadwickChief Operating Officer
Sale
12,905$79.36$1.0M48,297(D)

View →

May 26, 2026May 26 8:41 PMJEREMY CHADWICK
Proposed Sale
13,130$78.89$1.0M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 20, 2026Jan 20 11:30 PMPamela EspositoDirector
Option Exercise
5,500$49.105,000(D)

View →

Dec 31, 2025Dec 31 10:23 PMNello MainolfiDirector, Chief Executive Officer
Option Exercise
30,000$2.08275,559(D)

View →

← Previous

Page 3 of 3